Latest filing published 03 Feb 2016 for ARIAD PHARMACEUTICALS INC. Read the official filing
No signal scores available.
This profile gathers the share dealings of Daniel M. Bollag in Ariad Pharmaceuticals Inc. In total, 2 filings cover trades dated 1 February 2016.
No open-market purchase appears, only 1 sale. The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 1 option exercise.
On 3 February 2016 came the latest disclosure, an option exercise in Ariad Pharmaceuticals Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations